Literature DB >> 215819

Mineralocorticoids, salt balance and blood pressure after prolonged ACTH administration in juvenile hypertension.

W Rauh, L S Levine, K Gottesdiener, M I New.   

Abstract

The effect of a 5 day ACTH test (40 U/24 h) on plasma aldosterone (aldo), deoxycorticosterone (DOC), plasma renin activity (PRA) and urinary excretion of aldosterone-pH1-conjugate (pH-1-aldo) and tetrahydro-DOC (TH-DOC) was investigated in 8 normotensive children (group I), 8 patients with hypertension of unknown origin (group II), and 4 hypertensive children with dexamethasone suppressible hyperaldosteronism (DSH) (group III). Changes in blood pressure and sodium balance were studied in all groups. Under baseline conditions there was no hormonal difference between group I and II. In contrast, the children in group III had a suppressed PRA and a 1.5--2 fold elevation of aldo and DOC. Plasma DOC and urinary THDOC increased continuously 10--50 fold in all groups during the ACTH test. Aldo rose transiently 2--4 fold on the first day of ACTH and fell subsequently below baseline levels in group I and II. The children with DSH (group III), however, showed an unusual, sustained aldo stimulation with ACTH. PRA decreased significantly after ACTH in group I and II. Sodium retention aTH administration. The highest blood pressure rise was observed in group III (from 124/72 to 139/90 mm Hg). The blood pressure response to ACTH was partly sodium dependent. Although aldo and DOC and sodium retention may contribute to the ACTH induced blood pressure elevation, other factors must play a role.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 215819     DOI: 10.1007/bf01477468

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  28 in total

1.  Adjustment to aldosterone or desoxycorticosterone acetate induced sodium retention in patients with Addison's disease.

Authors:  J T AUGUST; D H NELSON
Journal:  J Clin Invest       Date:  1959-11       Impact factor: 14.808

2.  Response of normal subjects to large amounts of aldosterone.

Authors:  J T AUGUST; D H NELSON; G W THORN
Journal:  J Clin Invest       Date:  1958-11       Impact factor: 14.808

3.  Changes in vascular smooth muscle sensitivity to vasoconstrictor agents induced by corticosteroids, adrenalectomy and differing salt intake in rats.

Authors:  A Schömig; B Lüth; R Dietz; F Gross
Journal:  Clin Sci Mol Med Suppl       Date:  1976-12

4.  Effects of ACTH and salt on blood pressure and steroid secretion in rats.

Authors:  A F De Nicola; I J De la Riva; N Basso; V Dahl; S Kaplan
Journal:  Acta Physiol Lat Am       Date:  1972

5.  Plasma desoxycorticosterone levels in man with simultaneous measurement of aldosterone, corticosterone, cortisol and 11-deoxycortisol.

Authors:  C J Oddie; J P Coghlan; B A Scoggins
Journal:  J Clin Endocrinol Metab       Date:  1972-06       Impact factor: 5.958

6.  Plasma deoxycorticosterone in man.

Authors:  R D Brown; C A Strott
Journal:  J Clin Endocrinol Metab       Date:  1971-06       Impact factor: 5.958

7.  In vivo conversion of corticosterone into aldosterone in rats treated with ACTH or submitted to stress.

Authors:  P Vecsei; H Kessler
Journal:  Experientia       Date:  1970-09-26

8.  The effect of prolonged intravenous infusion of aldosterone in a normal human subject.

Authors:  J K Dawborn
Journal:  Med J Aust       Date:  1969-05-24       Impact factor: 7.738

9.  The role of 11-deoxycorticosterone in human hypertension.

Authors:  S Y Tan; R H Noth; P J Mulrow
Journal:  Clin Sci Mol Med Suppl       Date:  1976-12

10.  Evidence for an unidentified ACTH-induced steroid hormone causing hypertension.

Authors:  M I New; R E Peterson; P Saenger; L S Levine
Journal:  J Clin Endocrinol Metab       Date:  1976-12       Impact factor: 5.958

View more
  7 in total

1.  Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  P W Speiser; J Dupont; D Zhu; J Serrat; M Buegeleisen; M T Tusie-Luna; M Lesser; M I New; P C White
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

2.  Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency.

Authors:  L Pascoe; K M Curnow; L Slutsker; A Rösler; P C White
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

3.  High frequency of nonclassical steroid 21-hydroxylase deficiency.

Authors:  P W Speiser; B Dupont; P Rubinstein; A Piazza; A Kastelan; M I New
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

4.  Dexamethasone-suppressible hyperaldosteronism: pathophysiology, clinical aspects, and new insights into the pathogenesis.

Authors:  F Fallo; N Sonino; M Boscaro; D Armanini; F Mantero; H G Dörr; D Knorr; U Kuhnle
Journal:  Klin Wochenschr       Date:  1987-05-15

5.  The highly conserved cardiac glycoside binding site of Na,K-ATPase plays a role in blood pressure regulation.

Authors:  Iva Dostanic-Larson; James W Van Huysse; John N Lorenz; Jerry B Lingrel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-21       Impact factor: 11.205

6.  Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2.

Authors:  L Pascoe; K M Curnow; L Slutsker; J M Connell; P W Speiser; M I New; P C White
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

Review 7.  Effects of Chronic ACTH Excess on Human Adrenal Cortex.

Authors:  Xavier Bertagna
Journal:  Front Endocrinol (Lausanne)       Date:  2017-03-08       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.